Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Neuronax

Neuronax
2003 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$1.24M LATEST DEAL AMOUNT
7 INVESTORS
Description

Operator of a biotechnological company designed to develop candidate-drugs. The company's candidate-drugs support neural repair in order to treat traumatic or severe degenerative disorders of the central nervous system, enabling patients to begin treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Biopôle Clermont Limagne
  • Saint Beauzire
  • 63360 Clermont-Ferrand
  • France

+33 04 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Neuronax’s full profile, request a free trial.

Neuronax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 19-Dec-2014 $1.24M 00.000 Completed Profitable
1. Grant 01-Oct-2012 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Neuronax Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Angelor Capitale Angel Group Minority 000 0000 000000 0
Auvergne Business Angels Angel Group Minority 000 0000 000000 0
FaDiese Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
JEREMIE Auvergne Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Neuronax Executive Team (5)

Name Title Board
Seat
Contact
Info
Yann Godfrin Ph.D Chief Executive Officer & Chairman
Pierre-Yves Simonin Co-Founder

3 Former Executives

You’re viewing 2 of 5 executives. Get the full list »

Neuronax Board Members (3)

Name Representing Role Since Contact
Info
François Miceli Sofimac Investment Managers Supervisory Board Member 000 0000
Philippe du Mesnil Self Supervisory Board Member 000 0000
Yann Godfrin Ph.D Neuronax Chief Executive Officer & Chairman 000 0000